0
Axsome Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
44.8
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−125
FY22:
−180
FY23:
−232
FY24:
−281
FY25:
−167
(positive)
millions USD
FY21:
−125
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−187
FY23:
−238
FY24:
−287
FY25:
−184
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−187
FY23:
−239
FY24:
−287
FY25:
−183
All amounts in millions USD